Personalis, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PSNL | NEO | CSTL | MYGN | BLLN | BDSX | |
|---|---|---|---|---|---|---|
| Market cap | 1.69B | 2.22B | 1.09B | 575.81M | 5.37B | 226.74M |
| P/E (TTM) | — | — | — | — | 180.8 | — |
| Forward P/E | -16.3 | 54.5 | -38.2 | -10.2 | 76.7 | -97.7 |
| Price/book | 6.2 | 2.8 | 2.3 | 1.9 | 9.9 | 24.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +119.76% | +61.36% | +4.68% | −4.90% | +4.54% | +144.77% |
| Today | +0.25% | +1.90% | +1.74% | −0.33% | +3.11% | +2.09% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All PSNL news ›Caring for the whole person: What role does cura personalis play at Loyola?
As a Jesuit institution, Loyola publicly commits to upholding Ignatian values like cura personalis, which translates to “care for the whole person.” Loyola students and members of faith have competing outlooks on what role cura personalis…
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
BioSpace Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (NASDAQ: PSNL) announced today
Critical Survey: Seer (NASDAQ:SEER) and Personalis (NASDAQ:PSNL)
Posted by Kim Johansen on Oct 31st, 2026 Personalis (NASDAQ:PSNL – Get Free Report) and Seer (NASDAQ:SEER – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies…
Personalis (PSNL) Expected to Post Quarterly Earnings on Tuesday
Posted by Michael Walen on Oct 27th, 2026 Shares of PSNL stock opened at $15.88 on Tuesday. The company’s fifty day moving average price is $16.27 and its two-hundred day moving average price is $11.17. The firm has a market capitalization…
Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
WISeQey Issues CEO Letter to Shareholders: Building an Intelligent, Secure Platform for the Intelligence Age JFrog Closes the Shadow AI Blind Spot: Unveils AI-SEC to Control Every AI Agent, Skill, and Model, from Developer to Production…
Personalis expects Tempus acquisition in late 2026
Supermicro Provides First Quarter of Fiscal Year 2027 Preliminary Business Update INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science Employee equity awards, benefits and savings plans have transition…
Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test
Lithium Africa Receives Two Non-Binding Offers to Fund the Springbok Project, Including a US$60 Million Investment Proposal Mercantile Bank Corporation Announces Robust Third Quarter 2026 Results Commercial availability follows an Early…
In Brief Personalis, Tempus, AstraZeneca, Summit, ARUP, More
In Brief This Week: Personalis, Tempus, AstraZeneca, Summit, ARUP, FDA, Agilent, Abbvie, More Genome Web NEW YORK - Investment firm BTIG downgraded Personalis from Buy to Neutral this week based on the expectation that its acquisition by…
Tempus AI, Personalis saw US merger antitrust waiting period expire | MLex | Specialist news and analysis on legal risk and regulation
MLex Summary: The US merger antitrust waiting period for a deal between Biotechnology firms Tempus AI and Personalis expired on Oct. 2, 30 days after a pull-and-refile of the premerger form for the transaction, according to a securities…
Personalis downgraded at BTIG on likely Tempus takeover
Personalis (PSNL) stock slips as BTIG downgrades the cancer test maker, noting that Tempus AI (TEM) will complete its $1.5B M&A deal with the company. Read more here. BTIG on Tuesday downgraded Personalis (PSNL) to Neutral from Buy, noting…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net5
- themarketsdaily.com2
- biospace.com1
- genomeweb.com1
- investors.personalis.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.